AP2IX-4 is a cell cycle-regulated nuclear AP2-domain transcription factor in Toxoplasma gondii that represses bradyzoite-specific genes during the tachyzoite-to-bradyzoite stage conversion (PMID:28317026). AP2IX-4 is dispensable for tachyzoite replication, but its loss causes dramatic elevation of bradyzoite transcripts beyond normal stress-induced levels, reduced tissue cyst formation in vitro, and reduced brain cyst burden in chronically infected mice, all reversed by complementation (PMID:28317026). Biochemically, AP2IX-4 is a component of the MORC transcriptional repressor complex, co-expressed and associated with AP2XII-2 during S/M phase (PMID:32938695). AP2IX-4 mRNA exhibits a cyclical expression profile in dividing tachyzoites, with peak expression in the S/M-subtranscriptome, and the AP2IX-4 protein shows a sharp peak of expression in the same timeframe as its mRNA, suggesting post-transcriptional mechanisms may regulate protein delivery (PMID:20865045). The precise genomic targets and the mechanism linking DNA binding to repression have not been characterized in the available corpus.